Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016

A care cascade is a critical tool for evaluating delivery of care for chronic infections across sequential stages, starting with diagnosis and ending with viral suppression. However, there have been few data describing the hepatitis B virus (HBV) care cascade among people living with HIV infection who have HBV coinfection. We conducted a cross-sectional study among people living with HIV and HBV coinfection receiving care between January 1, 2012 and December 31, 2016 within 13 United States and Canadian clinical cohorts contributing data to the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). We evaluated each of the steps in this cascade, including: 1) laboratory-confirmed HBV infection, 2) tenofovir-based or entecavir-based HBV therapy prescribed, 3) HBV DNA measured during treatment, and 4) viral suppression achieved via undetectable HBV DNA. Among 3,953 persons with laboratory-confirmed HBV (median age, 50 years; 6.5% female; 43.8% were Black; 7.1% were Hispanic), 3,592 (90.9%; 95% confidence interval, 90.0-91.8%) were prescribed tenofovir-based antiretroviral therapy or entecavir along with their antiretroviral therapy regimen, 2,281 (57.7%; 95% confidence interval, 56.2-59.2%) had HBV DNA measured while on therapy, and 1,624 (41.1%; 95% confidence interval, 39.5-42.6) achieved an undetectable HBV DNA during HBV treatment. Our study identified significant gaps in measurement of HBV DNA and suppression of HBV viremia among people living with HIV and HBV coinfection in the United States and Canada. Periodic evaluation of the HBV care cascade among persons with HIV/HBV will be critical to monitoring success in completion of each step

Naphthalic anhydride increases tolerance of common bean to herbicides

The aim of this work was to evaluate the use of the naphthalic anhydride safener on the protection of common bean cultivars BRS-Estilo (carioca) and BRS-Esplendor (black) from negative effects of herbicides. Two experiments were conducted, one for each cultivar in a complete randomized design with five replications, in a 6 × 3 factorial scheme, with six herbicide treatments: bentazon, fluazifop-P + fomesafen, bentazon + imazamox, fomesafen, cloransulam, and control without application, and three naphthalic anhydride treatments: without application, foliar application, and application via seed treatment. Visible injuries at 7, 14 and 21 days after application, photosystem II electron transport rate, and plant dry weight were evaluated. The naphthalic anhydride applied via foliar, and seed treatment reduced significantly the visible injuries in relation to the control when using the herbicides bentazon, fluazifop-P + fomesafen, bentazon + imazamox, and cloransulam. The photosystem II electron transport rate was protected by anhydride applied via foliar and seed treatment when using the herbicides bentazon, fluazifop-P + fomesafen and bentazon + + imazamox. The application of naphthalic anhydride via seed treatment protected the BRS-Estilo and BRS-Esplendor common bean cultivars, with no reductions in the plant dry weight when using the herbicides fluazifop-P + fomesafen, and fomesafen. The use of naphthalic anhydride via seed treatment and foliar application protected BRS-Estilo and BRSEsplendor common bean cultivars, from the negative effects of fluazifop-P + fomesafen and fomesafen herbicides. Thus, this practice has potential to be used in common beans